ARMP — Armata Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Armata Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	10.3	14.9	13.5	9.29	8.69
Net Total Receivables	—	—	3.36	0.744	0.472
Prepaid Expenses
Total Other Current Assets
Total Current Assets	15	27	19.2	11.3	10.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	38.1	46.7	57.3	54.9	46.1
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	69.8	95.8	98.4	86.4	76.9
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.81	24.9	16.5	48.2	8.95
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	44.4	59.8	130	134	295
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	25.4	36.1	-32.1	-48	-219
Total Liabilities & Shareholders' Equity	69.8	95.8	98.4	86.4	76.9
Total Common Shares Outstanding